Related Experiment Videos
[Simvastatin-induced dermatomyositis]
A Rasch1, M Schimmer, C A Sander
1Eduard-Arning-Klinik für Dermatologie und Allergologie, Asklepios Klinik St. Georg , Lohmühlenstrasse 5, 20099, Hamburg. raschastrid@hotmail.com
Summary
Simvastatin, a common cholesterol-lowering drug, may trigger dermatomyositis, a rare autoimmune condition. This case report highlights simvastatin as a potential cause of this serious side effect.
Area of Science:
- Rheumatology
- Dermatology
- Pharmacology
Background:
- Dermatomyositis is a rare autoimmune disease causing muscle and skin inflammation.
- Statins are widely prescribed lipid-lowering drugs.
- Previous reports linked other statins, like pravastatin, to rare musculocutaneous syndromes.
Observation:
- A 71-year-old woman developed dermatomyositis.
- The patient had positive Mi-2-Antibodies, a specific marker for dermatomyositis.
- Her condition emerged after treatment with simvastatin.
Findings:
- This is the first reported case of simvastatin-induced dermatomyositis.
- The patient's presentation and antibody profile were consistent with dermatomyositis.
- The temporal association suggests simvastatin as a potential trigger.
Implications:
- Simvastatin should be considered a potential cause of dermatomyositis.
- This finding is significant given the increasing use of statins.
- Further research is needed to confirm this association and understand the mechanism.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...